XML 54 R45.htm IDEA: XBRL DOCUMENT
v3.23.3

Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details) - Armata $ / shares in Units, $ in Millions |  |  |  | 3 Months Ended | 6 Months Ended | 9 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Jul. 10, 2023 USD ($) | Jan. 10, 2023 USD ($) $ / shares | Feb. 09, 2022 USD ($) $ / shares shares | Sep. 30, 2023 USD ($) Director | Sep. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) shares | Mar. 31, 2021 USD ($) shares | Mar. 31, 2020 USD ($) shares | Jun. 30, 2023 Tranche | Sep. 30, 2023 USD ($) Director | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($)
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Number of tranches | Tranche |  |  |  |  |  |  |  |  | 2 |  |  |
Percentage of maximum voting rights |  |  | 49.50% |  |  |  |  |  | 49.50% |  |  |
Number of Investee's Board members currently representing the Company | Director |  |  |  | 3 |  |  |  |  |  | 3 |  |
Special terms on re-designating board member to board of investee |  |  | In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least 12.5% of the outstanding shares of Armata’s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata’s board of directors, and for so long as the Company and ISO hold at least 8%, but less than 12.5%, of the outstanding shares of Armata’s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata’s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement. |  |  |  |  |  |  |  |  |
Credit and Security Agreement |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Term loan facility in aggregate amount | $ 25.0 |  |  |  |  |  |  |  |  |  |  |
Debt Instrument, annual interest rate | 14.00% |  |  |  |  |  |  |  |  |  |  |
Debt instrument maturity date | Jan. 10, 2025 |  |  |  |  |  |  |  |  |  |  |
Consolidated Investees |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Equity method investment ownership percentage |  |  |  | 69.40% |  |  |  |  |  | 69.40% |  | 69.40%
Two Directors |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Armata outstanding shares percentage |  |  | 12.50% |  |  |  |  |  |  |  |  |
Secured Convertible Credit Agreement |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Debt instrument, description |  | On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the “Credit Agreement”) with Armata, under which we extended a one-year convertible note (the "Armata Convertible Note") in an aggregate amount of $30.0 million at an interest rate of 8.0% per annum. |  |  |  |  |  |  |  |  |  |
Term loan facility in aggregate amount |  | $ 30.0 |  |  |  |  |  |  |  |  |  |
Debt Instrument, annual interest rate |  | 8.00% |  |  |  |  |  |  |  |  |  |
Debt instrument, term |  | 1 year |  |  |  |  |  |  |  |  |  |
Common stock and warrants |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Amount of securities purchase agreement |  |  |  |  |  |  |  | $ 25.0 |  |  |  |
Unrealized loss |  |  |  |  |  |  |  |  |  |  | $ 35.3 |
Unrealized gain |  |  |  |  | $ 11.7 |  |  |  |  |  |  |
Warrants purchased in 2020 |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased under the securities purchase agreement | shares |  |  |  |  |  |  |  | 8,710,800 |  |  |  |
Exercise price of warrants | $ / shares |  | $ 2.87 |  |  |  |  |  |  |  |  |  |
Term of warrants |  | 5 years |  |  |  |  |  |  |  |  |  |
Warrants purchased in 2021 |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  | $ 3.25 |  |  |  |  |  |  |  |  |  |
Term of warrants |  | 5 years |  |  |  |  |  |  |  |  |  |
Warrants purchased in 2022 |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  | $ 5 |  |  |  |  |  |  |  |  |  |
Term of warrants |  | 5 years |  |  |  |  |  |  |  |  |  |
Warrants |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Equity method investments at fair value |  |  |  | $ 31.8 |  |  |  |  |  | $ 31.8 |  | $ 8.1
Unrealized gain |  |  |  |  |  |  |  |  |  | 67.9 |  |
Common stock |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Number of shares to be purchased under the securities purchase agreement | shares |  |  |  |  |  |  |  | 8,710,800 |  |  |  |
Equity method investments at fair value |  |  |  | 75.2 |  |  |  |  |  | 75.2 |  | $ 31.1
Unrealized gain |  |  |  | 72.0 |  |  |  |  |  |  |  |
Armata Convertible Note |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Equity method investments at fair value |  |  |  | 49.7 |  |  |  |  |  | 49.7 |  |
Unrealized gain |  |  |  | 18.5 |  |  |  |  |  | 19.6 |  |
Armata Term Loan |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Equity method investments at fair value |  |  |  | 26.2 |  |  |  |  |  | 26.2 |  |
Unrealized gain |  |  |  | $ 1.1 |  |  |  |  |  | $ 1.1 |  |
Minimum [Member] | One Director |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Armata outstanding shares percentage |  |  | 8.00% |  |  |  |  |  |  |  |  |
Maximum [Member] | One Director |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Armata outstanding shares percentage |  |  | 12.50% |  |  |  |  |  |  |  |  |
Innoviva Strategic Opportunities, LLC | Common stock and warrants |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Amount of securities purchase agreement |  |  | $ 45.0 |  |  |  | $ 20.0 |  |  |  |  |
Innoviva Strategic Opportunities, LLC | Warrants |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants to be purchased under the securities purchase agreement | shares |  |  | 4,500,000 |  |  |  | 6,153,847 |  |  |  |  |
Exercise price of warrants | $ / shares |  |  | $ 5 |  |  |  |  |  |  |  |  |
Innoviva Strategic Opportunities, LLC | Common stock |  |  |  |  |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |  |  |  |  |
Number of shares to be purchased under the securities purchase agreement | shares |  |  |  |  |  | 1,212,122 |  |  |  |  |  |
Number of shares to be purchased under the securities purchase agreement | shares |  |  | 9,000,000 |  |  |  |  |  |  |  |  |
Number of warrants to be purchased under the securities purchase agreement | shares |  |  |  |  |  |  | 6,153,847 |  |  |  |  |
Amount of securities purchase agreement |  |  |  |  |  | $ 4.0 |  |  |  |  |  |

X
- Definition The number of the Company's Board members currently serving on the Investee's Board. + References No definition available. + Details
Name: | inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
Namespace Prefix: | inva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
Namespace Prefix: | inva_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementAmount
Namespace Prefix: | inva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of tranches in which the Company agreed to purchase common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementNumberOfTranches
Namespace Prefix: | inva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The total number of shares to be purchased under the terms of a securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement
Namespace Prefix: | inva_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The total number of warrants to be purchased under the terms of a securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement
Namespace Prefix: | inva_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Special Terms on amended and restated investor rights agreement. + References No definition available. + Details
Name: | inva_SpecialTermReDesignatingBoardMemberToBoardOfInvestee
Namespace Prefix: | inva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of maximum voting rights under voting agreement. + References No definition available. + Details
Name: | inva_VotingAgreementMaximumVotingRightsPercent
Namespace Prefix: | inva_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(13)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 942 -SubTopic 470 -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3 + Details
Name: | us-gaap_DebtInstrumentDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contractual interest rate for funds borrowed, under the debt agreement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(2)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_DebtInstrumentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A + Details
Name: | us-gaap_EquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4 + Details
Name: | us-gaap_EquitySecuritiesFvNiUnrealizedGain
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4 + Details
Name: | us-gaap_EquitySecuritiesFvNiUnrealizedLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A + Details
Name: | us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=inva_CreditAndSecurityAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inva_ConsolidatedInvesteesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=inva_TwoDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=inva_SecuredConvertibleCreditAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_CommonStockAndWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_ArmataConvertibleNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_ArmataTermLoanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=inva_OneDirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |